T2 Biosystems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of T2 Biosystems generated cash of -$48,136,000, which is more than the previous year. Cash used in financing activities reached the amount of $52,688,000 last year. Net change in cash is therefore $4,360,000.
Cash Flow
| 2014 | -28.18M | -2.08M | 73.91M |
|---|---|---|---|
| 2015 | -37.46M | -7.89M | 45.17M |
| 2016 | -46.44M | -5.48M | 51.75M |
| 2017 | -47.71M | -2.47M | 18.50M |
| 2018 | -40.13M | -593K | 49.65M |
| 2019 | -45.36M | -761K | 6.35M |
| 2020 | -43.21M | -36.26M | 85.60M |
| 2021 | -38.87M | 24.79M | 20.53M |
| 2022 | -50.62M | 9.65M | 29.05M |
| 2023 | -48.13M | -192K | 52.68M |
TTOO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.88M | 23.79M | 17.34M | 11.21M | 50.98M | 42.05M | 73.48M | 73.66M | 73.84M | 30.19M |
Operating activities | ||||||||||
Net income | -50.07M | -62.00M | -49.24M | -46.79M | -59.00M | -51.15M | -62.42M | -54.80M | -45.29M | -31.39M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 859K | 2.27M | 2.53M | 3.15M | 3.64M | 2.44M | 2.94M | 2.28M | 1.46M | 691K |
Stock-based compensation expense | 4.35M | 6.49M | 7.09M | 3.91M | 5.45M | 0 | 4.79M | 4.84M | 4.16M | 1.65M |
| Deferred income tax benefit | 4.35M | 6.49M | 7.09M | 3.91M | 5.45M | 0 | 4.79M | 4.84M | 4.16M | 1.65M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 743K | 2.97M | -35K | -2.27M | -1.03M | -1.31M | -140K | 42K | -168K | -201K |
Inventories | -744K | -949K | -1.94M | 441K | -914K | -1.08M | -110K | -120K | -568K | -115K |
Accounts payable | 231K | -1.56M | 761K | -1.65M | 2.96M | 121K | -314K | -61K | 177K | -208K |
Cash generated by operating activities | -48.13M | -50.62M | -38.87M | -43.21M | -45.36M | -40.13M | -47.71M | -46.44M | -37.46M | -28.18M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -50.71M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -192K | -339K | -460K | -804K | -761K | -593K | -2.47M | -5.48M | -7.97M | -2.08M |
Acquisitions Net | 0 | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -192K | 9.65M | 24.79M | -36.26M | -761K | -593K | -2.47M | -5.48M | -7.89M | -2.08M |
Financing activities | ||||||||||
Common Stock Issued | 52.73M | 29.62M | 20.53M | 85.31M | 6.65M | 51.20M | 18.64M | 40.35M | 35.48M | 58.24M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -330K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -882K | -1.54M | -1.19M | -32.40M | 9.69M | -4.03M |
Cash used in financing activities | 52.68M | 29.05M | 20.53M | 85.60M | 6.35M | 49.65M | 18.50M | 51.75M | 45.17M | 73.91M |
Net Change In Cash | 4.36M | -11.91M | 6.45M | 6.13M | -39.77M | 8.92M | -31.68M | -174K | -187K | 43.65M |
Cash at end of period | 16.24M | 11.88M | 23.79M | 17.34M | 11.21M | 50.98M | 41.79M | 73.48M | 73.66M | 73.84M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |